期刊
JOURNAL OF RENAL NUTRITION
卷 31, 期 2, 页码 116-+出版社
W B SAUNDERS CO-ELSEVIER INC
DOI: 10.1053/j.jrn.2020.05.002
关键词
-
资金
- Academy of Nutrition and Dietetics
- National Institutes of Health (NIH) T32 [AR065971-04]
- Keryx Pharmaceuticals
The updated Clinical Practice Guidelines for nutrition in chronic kidney disease provide valuable recommendations for nutrition screening, assessment, macronutrients, and electrolytes, with a special focus on early detection and prevention of kidney disease. The guidelines suggest dietary protein intake ranges for CKD patients and emphasize the importance of individualized medical nutrition therapy for slowing down disease progression. Stakeholders are encouraged to collaborate in strengthening the evidence base through standardized outcomes and well-designed studies in CKD patients.
The Academy of Nutrition and Dietetics and the National Kidney Foundation collaborated to provide an update to the Clinical Practice Guidelines (CPG) for nutrition in chronic kidney disease (CKD). These guidelines provide a valuable update to many aspects of the nutrition care process. They include changes in the recommendations for nutrition screening and assessment, macronutrients, and targets for electrolytes and minerals. The International Society of Renal Nutrition and Metabolism assembled a special review panel of experts and evaluated these recommendations prior to public review. As one of the highlights of the CPG, the recommended dietary protein intake range for patients with diabetic kidney disease is 0.6-0.8 g/kg/day, whereas for CKD patients without diabetes it is 0.55-0.6 g/kg/day. The International Society of Renal Nutrition and Metabolism endorses the CPG with the suggestion that clinicians may consider a more streamlined target of 0.6-0.8 g/ kg/day, regardless of CKD etiology, while striving to achieve intakes closer to 0.6 g/kg/day. For implementation of these guidelines, it will be important that all stakeholders work to detect kidney disease early to ensure effective primary and secondary prevention. Once identified, patients should be referred to registered dietitians or the region-specific equivalent, for individualized medical nutrition therapy to slow the progression of CKD. As we turn our attention to the new CPG, we as the renal nutrition community should come together to strengthen the evidence base by standardizing outcomes, increasing collaboration, and funding well-designed observational studies and randomized controlled trials with nutritional and dietary interventions in patients with CKD. (c) 2020 by the National Kidney Foundation, Inc. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据